Patents Examined by Arun Chakrabarti
-
Patent number: 7001721Abstract: Disclosed are methods for determining the presence or absence of a target nucleic acid (e.g. DNA) sequence in a sample nucleic acid, the method comprising: (a) exposing the sample to a detection agent comprising a colloid metal surface associated with a SER(R)S active species (SAS) such as an azo dye and with a target binding species (TBS) which may be PNA which is complementary to the target, and (b) observing the sample agent mixture using SER(R)S to detect any surface enhancement of the label wherein the binding of the TBS to the target sequence causes surface enhancement SAS.Type: GrantFiled: May 20, 1999Date of Patent: February 21, 2006Assignee: University of StrathclydeInventors: David Mark Whitcombe, Duncan Graham, William Ewen Smith
-
Patent number: 6994960Abstract: A method of detecting a mutation or a difference of one or more nucleotides between a nucleic acid molecule to be tested and a reference nucleic acid molecule, said method comprising subjecting the test nucleic acid molecule to base specific cleavage to generate oligonucleotide fragments, separating the resulting oligonucleotide fragments based on mass by MALDI-ATOF MS and/or other equivalent procedure to produce a fingerprint of then oligonucleotide fragments comprising one or more peaks wherein a peak represents the mass of each fragment and identifying an altered peak relative to a reference nucleic acid molecule subjected to the same procedure wherein the presence of an altered peak is indicative of a difference of one or more nucleotides in said tested nucleic acid molecule.Type: GrantFiled: May 28, 1998Date of Patent: February 7, 2006Assignee: The Walter and Eliza Hall Institute of Medical ResearchInventors: Simon Foote, Colleen Elso, Richard Simpson, Gavin Reid
-
Patent number: 6982147Abstract: An apparatus for assaying specific binding of a probe to a target, includes: a sample support; a light source; an optical train; a light detector; an electricity source; an electrical property detector; and a data analysis device adapted to: (a) compare an optical determination of binding with an electrical determination of binding, or (b) compare a pre-electrification determination of binding with a post-electrification determination of binding.Type: GrantFiled: April 10, 2002Date of Patent: January 3, 2006Assignee: Ingeneus CorporationInventor: Glen H. Erikson
-
Patent number: 6974670Abstract: The present invention relates to an oligonucleotide having a novel structure and a method of synthesizing nucleic acid by using the same as a primer. This oligonucleotide is provided at the 5?-side of the primer with a nucleotide sequence substantially the same as a region synthesized with this primer as the origin of synthesis. The present invention realizes synthesis of nucleic acid based on an isothermal reaction with a simple constitution of reagents. Further, the present invention provides a method of synthesizing highly specific nucleic acid on the basis of this method of synthesizing nucleic acid.Type: GrantFiled: April 24, 2002Date of Patent: December 13, 2005Assignee: Eiken Kagaku Kabushiki KaishaInventors: Tsugunori Notomi, Tetsu Hase
-
Patent number: 6969587Abstract: The present invention describes a method for separating or partially separating heteroduplex and homoduplex DNA molecules in a mixture. In the method, the mixture is applied to an anion-exchange chromatography medium. The heteroduplex and homoduplex molecules are eluted with a mobile phase containing an eluting salt, including an anion and a cation, a buffer, and preferably including an organic solvent. The eluting is carried out under conditions effective to at least partially denature the heteroduplexes (e.g., thermal or chemical denaturing) resulting in the separation of the heteroduplexes from the homoduplexes. The method has many applications including, but not limited to, detecting mutations and comparative DNA sequencing.Type: GrantFiled: January 6, 2001Date of Patent: November 29, 2005Inventor: Paul D. Taylor
-
Patent number: 6964847Abstract: The invention features a method for multiplexed analysis of a plurality of target nucleic acid sequences in a sample. The method provides a derivative nucleic acid for each target sequence analyzed and present in the sample.Type: GrantFiled: July 14, 2000Date of Patent: November 15, 2005Assignee: Packard Biosciences CompanyInventor: David F. Englert
-
Patent number: 6958215Abstract: A method of inhibiting the self-splicing of a Group I intron is disclosed. The method uses an oligonucleotide having a sequence essentially identical to a guide sequence found in the 5? flanking exon and terminates with a 3? ribonucleoside. Usually the oligonucleotide has N3??P5? phosphoramidate or N3??P5? thiophiosphoramidate linkages rather than phosphodiester linkages. A method of inhibiting the growth of organisms having Group I intron, particularly certain pathogenic fungi including P. carinii, C. albicans, and A. nidulans using the oglionucleotide is also provided.Type: GrantFiled: March 15, 2000Date of Patent: October 25, 2005Assignees: Geron Corporation, The University of RochesterInventors: Stephen M. Testa, Matthew D. Disney, Sergei M. Gryaznov, Douglas H. Turner
-
Patent number: 6924109Abstract: Methods for correlating genes and gene function are provided. Such methods generally involve selecting a candidate gene that appears to be correlated with a particular cellular state or activity and then validating the role of the candidate gene in establishment of such a cellular state or activity. Certain methods utilize RNA interference techniques in the validation process.Type: GrantFiled: April 3, 2002Date of Patent: August 2, 2005Assignee: AGY Therapeutics, Inc.Inventors: Thorsten Melcher, Keith Charles McFarland, Li Gan, Shiming Ye, Mirella Gonzalez-Zulueta
-
Patent number: 6921640Abstract: The present invention relates to a process for labeling a synthetic or natural ribonucleic acid (RNA). It also relates to RNA fragments, which have been labeled by fragmenting the RNA to free a terminal phosphate of each fragment for further reaction, and labeling each fragment at the freed terminal phosphate which is located at the 3? end and/or the 5? end of each fragment of the RNA, and to the use of such RNA fragments, for example, in the field of medical diagnosis.Type: GrantFiled: March 20, 2002Date of Patent: July 26, 2005Assignee: Bio MerieuxInventor: Ali Laayoun
-
Patent number: 6919175Abstract: A procedure for the release and isolation of nucleic acids from biological compartments of a sample always uses an instrument that can hold one or more sample processsing vessels, maintain the sample processing vessels at a constant temperature, shake the sample processing vessels and separate magnetic particles by means of magnetic force. This system greatly simplifies the isolation of nucleic acids.Type: GrantFiled: April 26, 2000Date of Patent: July 19, 2005Assignee: Roche Diagnostics GmbHInventors: Gerhard Bienhaus, Ulrich Schubert, Uwe Kolb, Burkhard Stolz, Manfred Pasch
-
Patent number: 6916613Abstract: The present invention is directed to methods, compositions, kits and apparatus to identify and detect the presence or absence of target analytes. The embodiments of the present invention have utility in medical diagnosis and analysis of various chemical compounds in specimens and samples, as well as the design of test kits and apparatus for implementing such methods.Type: GrantFiled: April 27, 2001Date of Patent: July 12, 2005Assignee: Q-RNA, Inc.Inventors: Alexander Munishkin, Abraham Grossman
-
Patent number: 6905823Abstract: A method is disclosed for rapid molecular profiling of tissue or other cellular specimens by placing a donor specimen in an assigned location in a recipient array, providing copies of the array, and performing a different biological analysis of each copy. The results of the different biological analyses are compared to determine if there are correlations between the results of the different biological analyses at each assigned location. In some embodiments, the specimens may be tissue specimens from different tumors, which are subjected to multiple parallel molecular (including genetic and immunological) analyses. The results of the parallel analyses are then used to detect common molecular characteristics of the genetic disorder type, which can subsequently be used in the diagnosis or treatment of the disease.Type: GrantFiled: October 4, 2001Date of Patent: June 14, 2005Assignee: Abbott LaboratoriesInventors: Olli-P Kallioniemi, Uwe Richard Müller, Guido Sauter, Juha Kononen, Maarit Barlund
-
Patent number: 6905825Abstract: A method for isolating and purifying nucleic acids with an improved recovery yield is provided. A mixed solution containing the nucleic acids, salts, and an organic solvent is contacted with an adsorption support to cause the nucleic acids to be adsorbed on the support. Then, the nucleic acids are desorbed from the support using an elution buffer. At least one compound containing 2 to 10 carbon atoms as selected from the group consisting of aliphatic ether, aliphatic ester, and aliphatic ketone is used as the organic solvent. The method improves the yield of nucleic acids collection, is easy to implement and less susceptible to contamination.Type: GrantFiled: December 19, 2001Date of Patent: June 14, 2005Assignee: Hitachi, Ltd.Inventors: Kyoko Kojima, Satoshi Ozawa
-
Patent number: 6905817Abstract: Methods for screening for agonists and antagonists of GPI-anchored independent intracellular signaling resulting in [Ca2+]i elevation, ERK1, ERK2 and CREB phosphorylation, and Src family kinase activation are described, as well as methods for treatment involving administration of agonists/antagonists of such signaling.Type: GrantFiled: October 1, 1999Date of Patent: June 14, 2005Assignee: Licestia Ltd.Inventors: Alexey Vladimirovich Titievsky, Dmitri Poteriaev, Urmas Arumäe, Mart Saarma
-
Patent number: 6900012Abstract: The present invention provides for the identification and cloning of functional plant centromeres in Arabidopsis. This will permit construction of stably inherited plant artificial chromosomes (PLACs) which can serve as vectors for the construction of transgenic plant and animal cells. In addition, information on the structure and function of these regions will prove valuable in isolating additional centromeric and centromere related genetic elements and polypeptides from other species.Type: GrantFiled: April 19, 2000Date of Patent: May 31, 2005Assignee: The University of ChicagoInventors: Daphne Kay Preuss, Gregory Paul Copenhaver
-
Patent number: 6893821Abstract: The present invention provides methods for modulating cell death in a eukaryotic cell, and methods for reducing DNA damage in a eukaryotic cell. The methods generally comprise modulating a biological activity of DNA-PK in a cell. The invention further provides methods of treating a condition related to cell death in an individual. The invention further provides methods of identifying agents which modulate a biological activity of DNA-PK, as well as agents identified by the methods. Methods of modulating an immune response using an identified agent are also provided.Type: GrantFiled: May 4, 2001Date of Patent: May 17, 2005Assignee: The Regents of the University of CaliforniaInventors: Eyal Raz, Augusto Lois, Kenji Takabayashi
-
Patent number: 6818395Abstract: Methods for high speed, high throughput analysis of polynucleotide sequences, and apparatuses with which to carry out the methods are provided in the invention.Type: GrantFiled: November 6, 2000Date of Patent: November 16, 2004Assignee: California Institute of TechnologyInventors: Stephen Quake, Marc Unger
-
Patent number: 6806047Abstract: Methods and compounds are provided for detecting target molecules in a sample using specific binding assays. In particular, methods are provided for detecting a nucleic acid target in a sample. In one embodiment, the method comprises hybridizing a nucleic acid target, comprising a target nucleic acid sequence, to a nucleic acid probe, comprising a probe nucleic acid sequence, wherein the target comprises a binding ligand. The hydridized target is contacted with a receptor comprising multiple sites capable of binding the binding ligand to complex the receptor to the binding ligand, and the receptor is contacted with an amplification reagent, comprising a plurality of the binding ligands, to complex the amplification reagent to the receptor. The presence of the complexed amplification reagent then is detected, for example, by detecting the presence of a detectable label, such as a fluorescent label, for example, on the receptor or the amplification reagent.Type: GrantFiled: February 6, 2001Date of Patent: October 19, 2004Assignee: Affymetrix, Inc.Inventors: Martin J. Goldberg, Govinda Rao S. Yelagalawadi, Eugene Yuji Tanimoto, Huu Minh Tran, Helin Dong, David Lockhart, Thomas B. Ryder, Janet A. Warrington, Jody Beecher
-
Patent number: 6783935Abstract: The present invention provides polynucleotides having base sequences of sequence Nos. 1 to 4, as polynucleotides having polymorphism sites capable of being useful indicators for prediction of validity of interferon therapy.Type: GrantFiled: March 22, 2001Date of Patent: August 31, 2004Assignee: Kabushiki Kaisha ToshibaInventors: Minako Hijikata, Shunji Mishiro, Yasuhiko Oota, Koji Hashimoto
-
Patent number: 6770443Abstract: Methods and equipment are provided for the mass spectrometric measurement of a large number of genotyping profiles, each formed by several tens to several hundreds of SNPs (single nucleotide polymorphisms). A multitude of chips each carrying an array of surface-bound oligonucleotide probes for mutations are synchronously processed. The chips are attached to plates such that they can be immersed in a multitude of wells with DNA samples requiring analysis while also serving directly as sample carriers in mass spectrometers. The multitude of wells can, for instance, take the form of microtitre plates. Primers may be used which possess a photolytically or chemically cleavable linker that bridges one base pair and does not hinder either the possibility of hybridization or enzymatic extension. Light or chemicals can then be used to cleave short chains particularly suitable for ionization by matrix assisted laser desorption and mass spectrometric analysis using time-of-flight mass spectrometers.Type: GrantFiled: March 15, 2002Date of Patent: August 3, 2004Assignee: Bruker Daltonik GmbHInventor: Jochen Franzen